144 related articles for article (PubMed ID: 7512464)
1. Long term effects of sustained release verapamil on the renal and systemic haemodynamic parameters in hypertensive patients with mild to severe chronic renal failure.
Schohn DC; Jahn HA; Maareck M
Drugs; 1993; 46 Suppl 2():113-9; discussion 119-20. PubMed ID: 7512464
[TBL] [Abstract][Full Text] [Related]
2. [Effects of sustained-release verapamil on hemodynamics and renal function of patients with moderate to severe chronic renal failure].
Schohn D; Maarek M; Jahn H
Presse Med; 1993 Nov; 22(37):1856-60. PubMed ID: 8115329
[TBL] [Abstract][Full Text] [Related]
3. Chronic effects of tertatolol on renal function in hypertensive patients with mild chronic renal failure.
Hannedouche T; Brouard R; Godin M; Kleinknecht D; Paillard F; Grünfeld JP
Nephrol Dial Transplant; 1991; 6(4):252-6. PubMed ID: 1679214
[TBL] [Abstract][Full Text] [Related]
4. Verapamil sustained-release in renal parenchymal hypertension: effect on blood pressure, kidney function, angiotensin II, aldosterone, arginine vasopressin, atrial natriuretic peptide, and lipoproteins.
Eiskjaer H; Pedersen EB; Rasmussen LM; Jespersen B
J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S17-22. PubMed ID: 2475677
[TBL] [Abstract][Full Text] [Related]
5. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
Svarstad E; Myking O; Ofstad J; Iversen BM
Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513
[TBL] [Abstract][Full Text] [Related]
6. Comparative renal hemodynamic effects of lisinopril, verapamil, and amlodipine in patients with chronic renal failure.
August P; Lenz T; Laragh JH
Am J Hypertens; 1993 Apr; 6(4):148S-154S. PubMed ID: 8389563
[TBL] [Abstract][Full Text] [Related]
7. [The effect of verapamil on cardio- and hemodynamics in rats with various models of hypertension].
Spasov AA; Gurbanov KG; Seredintseva NV; Paperno AA
Eksp Klin Farmakol; 1997; 60(3):30-3. PubMed ID: 9324394
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.
Goddard J; Johnston NR; Hand MF; Cumming AD; Rabelink TJ; Rankin AJ; Webb DJ
Circulation; 2004 Mar; 109(9):1186-93. PubMed ID: 14981006
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of verapamil in patients with essential hypertension.
Schmieder RE; Messerli FH; Garavaglia GE; Nunez BD
Circulation; 1987 May; 75(5):1030-6. PubMed ID: 3568303
[TBL] [Abstract][Full Text] [Related]
10. Sustained release verapamil in renal hypertension.
Eiskjaer H; Pedersen EB; Rasmussen LM; Jespersen B
Eur J Clin Pharmacol; 1988; 33(6):549-55. PubMed ID: 2966736
[TBL] [Abstract][Full Text] [Related]
11. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
Muijsers RB; Curran MP; Perry CM
Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112
[TBL] [Abstract][Full Text] [Related]
12. Junctional bradycardia with verapamil in renal failure--care required even with mild hyperkalaemia.
Hegazi MO; Aldabie G; Al-Mutairi S; El Sayed A
J Clin Pharm Ther; 2012 Dec; 37(6):726-8. PubMed ID: 22568727
[TBL] [Abstract][Full Text] [Related]
13. Effects of ACE inhibition on renal haemodynamics in essential hypertension and hypertension associated with chronic renal failure.
Sánchez RA; Traballi CA; Marcó EJ; Gilbert BH; Ramírez AJ; Long G
Drugs; 1991; 41 Suppl 1():25-30. PubMed ID: 1712268
[TBL] [Abstract][Full Text] [Related]
14. Sodium intake does not influence the effect of verapamil in hypertensive patients with mild renal insufficiency.
Ruilope LM; Casal MC; Guerrero L; Alcázar JM; Férnandez ML; Lahera V; Rodicio JL
Drugs; 1992; 44 Suppl 1():94-8. PubMed ID: 1283591
[TBL] [Abstract][Full Text] [Related]
15. Acute toxic effects of sustained-release verapamil in chronic renal failure.
Pritza DR; Bierman MH; Hammeke MD
Arch Intern Med; 1991 Oct; 151(10):2081-4. PubMed ID: 1843183
[TBL] [Abstract][Full Text] [Related]
16. Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.
Guidi E; Minetti EE; Cozzi MG
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):40-5. PubMed ID: 11984747
[TBL] [Abstract][Full Text] [Related]
17. Role of calcium channel blockers in protection against experimental renal injury.
Schrier RW
Am J Med; 1991 May; 90(5A):21S-26S. PubMed ID: 2039016
[TBL] [Abstract][Full Text] [Related]
18. The antihypertensive effect of verapamil in patients with chronic renal failure.
Rodicio JL; Alcazar JM; Ruilope LM
J Hum Hypertens; 1992 Dec; 6 Suppl 2():S41-3. PubMed ID: 1289513
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic responses to verapamil monotherapy in patients with renal disease.
Lenz T; Müller FB; Sotelo JE; Laragh JH; August P
Am J Hypertens; 1991 Dec; 4(12 Pt 1):939-43. PubMed ID: 1815650
[TBL] [Abstract][Full Text] [Related]
20. [Plasma levels and noninvasive hemodynamic profile of slow release verapamil (240 mg). A multicenter study].
Vulpis V; Seccia TM; Ricci S; Pirrelli A
Riv Eur Sci Med Farmacol; 1993; 15(5-6):227-35. PubMed ID: 7761676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
